Difference between revisions of "HAN5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(13 intermediate revisions by the same user not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 +
 +
__TOC__
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Head and Neck Tumours (5th Edition) Content</big>
 
|+<big>WHO Classification of Head and Neck Tumours (5th Edition) Content</big>
Line 17: Line 19:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
−
|[[GTS5:Hereditary_papillary_renal_carcinoma_(MET)|Hereditary papillary renal carcinoma (MET)]]
+
|
 +
==== CHAPTER 2 (NASAL, PARANASAL, AND SKULL BASE TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Respiratory_epithelial_adenomatoid_hamartoma|Respiratory epithelial adenomatoid hamartoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 28: Line 51:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Multiple_endocrine_neoplasia_type_2_(RET)|Multiple endocrine neoplasia type 2 (RET)]]
+
|[[HAN5:Seromucinous_hamartoma|Seromucinous hamartoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 39: Line 62:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Juvenile_polyposis_syndrome_(BMPR1A,_SMAD4)|Juvenile polyposis syndrome (BMPR1A, SMAD4)]]
+
|[[HAN5:Nasal_chondromesenchymal_hamartoma|Nasal chondromesenchymal hamartoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 50: Line 73:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_neuroblastoma_(ALK,_PHOX2B)|Hereditary neuroblastoma (ALK, PHOX2B)]]
+
|[[HAN5:Sinonasal_papilloma,_inverted_type|Sinonasal papilloma, inverted type]]
 
|Disease
 
|Disease
 
|
 
|
Line 61: Line 84:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Encephalocraniocutaneous_lipomatosis_(FGFR1)|Encephalocraniocutaneous lipomatosis (FGFR1)]]
+
|[[HAN5:Sinonasal_papilloma,_oncocytic_type|Sinonasal papilloma, oncocytic type]]
 
|Disease
 
|Disease
 
|
 
|
Line 72: Line 95:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Glucagon_cell_hyperplasia_and_neoplasia_(GCGR)|Glucagon cell hyperplasia and neoplasia (GCGR)]]
+
|[[HAN5:Sinonasal_papilloma,_exophytic_type|Sinonasal papilloma, exophytic type]]
 
|Disease
 
|Disease
 
|
 
|
Line 83: Line 106:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:McCune-Albright_syndrome_(GNAS)|McCune-Albright syndrome (GNAS)]]
+
|[[HAN5:Keratinizing_squamous_cell_carcinoma|Keratinizing squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 94: Line 117:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Sturge-Weber_syndrome_(GNAQ)|Sturge-Weber syndrome (GNAQ)]]
+
|[[HAN5:Non-keratinizing_squamous_cell_carcinoma|Non-keratinizing squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 105: Line 128:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]]
+
|[[HAN5:NUT_carcinoma|NUT carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 116: Line 139:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]]
+
|[[HAN5:SWI/SNF_complex-deficient_sinonasal_carcinoma|SWI/SNF complex-deficient sinonasal carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 127: Line 150:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Costello_syndrome_(HRAS)|Costello syndrome (HRAS)]]
+
|[[HAN5:Sinonasal_lymphoepithelial_carcinoma|Sinonasal lymphoepithelial carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 138: Line 161:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Noonan_syndrome_(Various_genes)|Noonan syndrome (Various genes)]]
+
|[[HAN5:Sinonasal_undifferentiated_carcinoma|Sinonasal undifferentiated carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 149: Line 172:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Schimmelpenning-Feuerstein-Mims_(HRAS,_KRAS)|Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)]]
+
|[[HAN5:Teratocarcinosarcoma|Teratocarcinosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 160: Line 183:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Carney_complex_(PRKAR1A,_PDE8B,_PDE11A)|Carney complex (PRKAR1A, PDE8B, PDE11A)]]
+
|[[HAN5:HPV-associated_multiphenotypic_sinonasal_carcinoma|HPV-associated multiphenotypic sinonasal carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 171: Line 194:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:PROS_syndrome_(PIK3CA)|PROS syndrome (PIK3CA)]]
+
|[[HAN5:Intestinal-type_sinonasal_adenocarcinoma|Intestinal-type sinonasal adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 182: Line 205:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]]
+
|[[HAN5:Non-intestinal-type_sinonasal_adenocarcinoma|Non-intestinal-type sinonasal adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 193: Line 216:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]]
+
|[[HAN5:Sinonasal_tract_angiofibroma_|Sinonasal tract angiofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 204: Line 227:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:AXIN2-associated_polyposis_(AXIN2)|AXIN2-associated polyposis (AXIN2)]]
+
|[[HAN5:Sinonasal_glomangiopericytoma|Sinonasal glomangiopericytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 215: Line 238:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Serrated_polyposis_(RNF43)|Serrated polyposis (RNF43)]]
+
|[[HAN5:Biphenotypic_sinonasal_sarcoma|Biphenotypic sinonasal sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 226: Line 249:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:WT1_related_tumour_predisposition_syndrome_(WT1)|WT1 related tumour predisposition syndrome (WT1)]]
+
|[[HAN5:Chordoma|Chordoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 237: Line 260:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:WAGR_syndrome_(WT1)|WAGR syndrome (WT1)]]
+
|[[HAN5:Sinonasal_ameloblastoma|Sinonasal ameloblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 248: Line 271:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Multiple_endocrine_neoplasia_type_1_(MEN1)|Multiple endocrine neoplasia type 1 (MEN1)]]
+
|[[HAN5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 259: Line 282:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Peutz-Jeghers_syndrome_(STK11)|Peutz-Jeghers syndrome (STK11)]]
+
|[[HAN5:Meningioma_of_the_sinonasal_tract,_ear,_and_temporal_bone|Meningioma of the sinonasal tract, ear, and temporal bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 270: Line 293:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]]
+
|[[HAN5:Olfactory_neuroblastoma|Olfactory neuroblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 281: Line 304:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 3 (NASOPHARYNGEAL  TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[GTS5:Naevoid_basal_cell_carcinoma_syndrome_-_Gorlin_syndrome_(PTCH1,_SUFU,_GPR161)|Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)]]
+
|[[HAN5:Hairy_polyp|Hairy polyp]]
 
|Disease
 
|Disease
 
|
 
|
Line 303: Line 336:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:SMO-related_Curry-Jones_syndrome_(SMO)|SMO-related Curry-Jones syndrome (SMO)]]
+
|[[HAN5:Salivary_gland_anlage_tumour|Salivary gland anlage tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 314: Line 347:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:ELP1-related_medulloblastoma_predisposition_syndrome(ELP1)|ELP1-related medulloblastoma predisposition syndrome(ELP1)]]
+
|[[HAN5:Low-grade_nasopharyngeal_papillary_adenocarcinoma|Low-grade nasopharyngeal papillary adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 325: Line 358:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Osteochondromatosis_(EXT1,_EXT2)|Osteochondromatosis (EXT1, EXT2)]]
+
|[[HAN5:Nasopharyngeal_carcinoma|Nasopharyngeal carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 336: Line 369:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Brooke-Spiegler_syndrome_(CYLD)|Brooke-Spiegler syndrome (CYLD)]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 4 (HYPOPHARYNGEAL, LARYNGEAL, TRACHEA, AND PARAPHARYNGEAL TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[GTS5:Tuberous_sclerosis_(TSC1,_TSC1)|Tuberous sclerosis (TSC1, TSC1)]]
+
|[[HAN5:Squamous_papilloma_and_papillomatosis|Squamous papilloma and papillomatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 358: Line 401:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:PTEN_hamartoma_tumour_syndrome_(PTEN)|PTEN hamartoma tumour syndrome (PTEN)]]
+
|[[HAN5:Laryngeal_and_hypopharyngeal_epithelial_dysplasia|Laryngeal and hypopharyngeal epithelial dysplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 369: Line 412:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Activated_Phosphatidylinositol-3-OH_kinase_&#948;_Syndrome_-_APDS_(PIK3CD)|Activated Phosphatidylinositol-3-OH kinase &#948; Syndrome - APDS (PIK3CD)]]
+
|[[HAN5:Conventional_squamous_cell_carcinoma|Conventional squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 380: Line 423:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Multiple_endocrine_neoplasia_type_5,_MAX_related_tumours_(MAX)|Multiple endocrine neoplasia type 5, MAX related tumours (MAX)]]
+
|[[HAN5:Verrucous_carcinoma_of_the_hypopharynx,_larynx,_trachea,_and_parapharyngeal_space|Verrucous carcinoma of the hypopharynx, larynx, trachea, and parapharyngeal space]]
 
|Disease
 
|Disease
 
|
 
|
Line 391: Line 434:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:MAFA-related_familial_insulinomatosis_(MAFA)|MAFA-related familial insulinomatosis (MAFA)]]
+
|[[HAN5:Basaloid_squamous_cell_carcinoma|Basaloid squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 402: Line 445:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Birt-Hogg-Dube_syndrome_(FLCN)|Birt-Hogg-Dube syndrome (FLCN)]]
+
|[[HAN5:Papillary_squamous_cell_carcinoma|Papillary squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 413: Line 456:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Familial_chordoma_(TBXT)|Familial chordoma (TBXT)]]
+
|[[HAN5:Spindle_cell_squamous_carcinoma|Spindle cell squamous carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 424: Line 467:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Hyperparathyroidism_jaw_tumour_syndrome_(CDC73)|Hyperparathyroidism jaw tumour syndrome (CDC73)]]
+
|[[HAN5:Adenosquamous_carcinoma|Adenosquamous carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 435: Line 478:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Von_Hippel-Lindau_syndrome_(VHL)|Von Hippel-Lindau syndrome (VHL)]]
+
|[[HAN5:Lymphoepithelial_carcinoma_of_the_larynx|Lymphoepithelial carcinoma of the larynx]]
 
|Disease
 
|Disease
 
|
 
|
Line 446: Line 489:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:SDH-deficient_tumour_syndrome_-_Hereditary_phaeochromocytoma-paraganglioma_syndromes_(SDHA,_SDHB,_SDHC,_SDHD,_SDHAF2)|SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)]]
+
|[[HAN5:Laryngeal_cartilaginous_tumours|Laryngeal cartilaginous tumours]]
 
|Disease
 
|Disease
 
|
 
|
Line 457: Line 500:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome_(FH)|Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 5 (SALIVARY GLAND TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[GTS5:Hereditary_tyrosinaemia_type_1_(FAH)|Hereditary tyrosinaemia type 1 (FAH)]]
+
|[[HAN5:Nodular_oncocytic_hyperplasia|Nodular oncocytic hyperplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 479: Line 532:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Li-Fraumeni_syndrome_(TP53)|Li-Fraumeni syndrome (TP53)]]
+
|[[HAN5:Lymphoepithelial_sialadenitis|Lymphoepithelial sialadenitis]]
 
|Disease
 
|Disease
 
|
 
|
Line 490: Line 543:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]]
+
|[[HAN5:Pleomorphic_adenoma|Pleomorphic adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 501: Line 554:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Multiple_endocrine_neoplasia_type_4_(CDKN1B)|Multiple endocrine neoplasia type 4 (CDKN1B)]]
+
|[[HAN5:Basal_cell_adenoma|Basal cell adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 512: Line 565:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:CDKN2A-related_tumour_predisposition_syndrome_(CDKN2A)|CDKN2A-related tumour predisposition syndrome (CDKN2A)]]
+
|[[HAN5:Warthin_tumour|Warthin tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 523: Line 576:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:CDK4-related_melanoma_predisposition_syndrome_(CDK4)|CDK4-related melanoma predisposition syndrome (CDK4)]]
+
|[[HAN5:Oncocytoma|Oncocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 534: Line 587:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Autoimmune_lymphoproliferative_syndrome_(FAS)|Autoimmune lymphoproliferative syndrome (FAS)]]
+
|[[HAN5:Salivary_gland_myoepithelioma|Salivary gland myoepithelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 545: Line 598:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Lynch_Syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)]]
+
|[[HAN5:Canalicular_adenoma|Canalicular adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 556: Line 609:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Muir-Torre_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)]]
+
|[[HAN5:Cystadenoma_of_the_salivary_glands|Cystadenoma of the salivary glands]]
 
|Disease
 
|Disease
 
|
 
|
Line 567: Line 620:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]]
+
|[[HAN5:Ductal_papillomas|Ductal papillomas]]
 
|Disease
 
|Disease
 
|
 
|
Line 578: Line 631:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
+
|[[HAN5:Sialadenoma_papilliferum|Sialadenoma papilliferum]]
 
|Disease
 
|Disease
 
|
 
|
Line 589: Line 642:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]]
+
|[[HAN5:Lymphadenoma_|Lymphadenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 600: Line 653:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]
+
|[[HAN5:Sebaceous_adenoma_|Sebaceous adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 611: Line 664:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Fanconi_anaemia_(FANC_genes)|Fanconi anaemia (FANC genes)]]
+
|[[HAN5:Intercalated_duct_adenoma_and_hyperplasia|Intercalated duct adenoma and hyperplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 622: Line 675:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:MUTYH-associated_polyposis_(MUTYH)|MUTYH-associated polyposis (MUTYH)]]
+
|[[HAN5:Striated_duct_adenoma|Striated duct adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 633: Line 686:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:NTHL1-related_tumour_syndrome_(NTHL1)|NTHL1-related tumour syndrome (NTHL1)]]
+
|[[HAN5:Sclerosing_polycystic_adenoma|Sclerosing polycystic adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 644: Line 697:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:MBD4-associated_neoplasia_syndrome_(MBD4)|MBD4-associated neoplasia syndrome (MBD4)]]
+
|[[HAN5:Keratocystoma|Keratocystoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 655: Line 708:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Xeroderma_Pigmentosum|Xeroderma Pigmentosum]]
+
|[[HAN5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 666: Line 719:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]]
+
|[[HAN5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 677: Line 730:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]]
+
|[[HAN5:Acinic_cell_carcinoma|Acinic cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 688: Line 741:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]]
+
|[[HAN5:Secretory_carcinoma|Secretory carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 699: Line 752:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Polymerase_proofreading-associated_polyposis_(POLD1,_POLE)|Polymerase proofreading-associated polyposis (POLD1, POLE)]]
+
|[[HAN5:Microsecretory_adenocarcinoma|Microsecretory adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 710: Line 763:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Bloom_syndrome_(BLM)|Bloom syndrome (BLM)]]
+
|[[HAN5:Polymorphous_adenocarcinoma|Polymorphous adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 721: Line 774:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Werner_syndrome_(WRN)|Werner syndrome (WRN)]]
+
|[[HAN5:Hyalinizing_clear_cell_carcinoma|Hyalinizing clear cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 732: Line 785:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Rothmund-Thomson_syndrome_(ANAPC1,_RECQL4)|Rothmund-Thomson syndrome (ANAPC1, RECQL4)]]
+
|[[HAN5:Basal_cell_adenocarcinoma|Basal cell adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 743: Line 796:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:DDX41-related_haematologic_tumour_predisposition_syndrome_(DDX41)|DDX41-related haematologic tumour predisposition syndrome (DDX41)]]
+
|[[HAN5:Intraductal_carcinoma_|Intraductal carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 754: Line 807:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Mosaic_variegated_aneuploidy_(BUB1B,_CEP57,_TRIP13,_BUB1,_BUB3)|Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)]]
+
|[[HAN5:Salivary_duct_carcinoma|Salivary duct carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 765: Line 818:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Klinefelter_syndrome|Klinefelter syndrome]]
+
|[[HAN5:Myoepithelial_carcinoma|Myoepithelial carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 776: Line 829:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Turner_syndrome|Turner syndrome]]
+
|[[HAN5:Epithelial-myoepithelial_carcinoma|Epithelial-myoepithelial carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 787: Line 840:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Down_syndrome|Down syndrome]]
+
|[[HAN5:Mucinous_adenocarcinoma|Mucinous adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 798: Line 851:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]]
+
|[[HAN5:Sclerosing_microcystic_adenocarcinoma|Sclerosing microcystic adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 809: Line 862:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]]
+
|[[HAN5:Carcinoma_ex_pleomorphic_adenoma|Carcinoma ex pleomorphic adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 820: Line 873:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Beckwith-Wiedemann_spectrum_(IGF2;_CDKN1C)|Beckwith-Wiedemann spectrum (IGF2; CDKN1C)]]
+
|[[HAN5:Carcinosarcoma_of_the_salivary_glands|Carcinosarcoma of the salivary glands]]
 
|Disease
 
|Disease
 
|
 
|
Line 831: Line 884:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Enchondromatosis_(IDH1,_IDH2)|Enchondromatosis (IDH1, IDH2)]]
+
|[[HAN5:Sebaceous_adenocarcinoma|Sebaceous adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 842: Line 895:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Rhabdoid_tumour_predisposition_syndrome_(SMARCB1,_SMARCA4)|Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)]]
+
|[[HAN5:Lymphoepithelial_carcinoma|Lymphoepithelial carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 853: Line 906:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Schwannomatosis_(SMARCB1,_LZTR1)|Schwannomatosis (SMARCB1, LZTR1)]]
+
|[[HAN5:Squamous_cell_carcinoma|Squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 864: Line 917:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Clear_cell_meningioma_predisposition_syndrome_(SMARCE1)|Clear cell meningioma predisposition syndrome (SMARCE1)]]
+
|[[HAN5:Sialoblastoma|Sialoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 875: Line 928:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:Weaver_syndrome_(EZH2)|Weaver syndrome (EZH2)]]
+
|[[HAN5:Salivary_carcinoma_NOS_and_emerging_entities|Salivary carcinoma NOS and emerging entities]]
 
|Disease
 
|Disease
 
|
 
|
Line 886: Line 939:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]]
+
|[[HAN5:Sialolipoma|Sialolipoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 897: Line 950:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 6 (ORAL CAVITY AND MOBILE TONGUE TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[GTS5:Goldenhar_syndrome_(MYT1,_SF3B2)|Goldenhar syndrome (MYT1, SF3B2)]]
+
|[[HAN5:Necrotizing_sialometaplasia|Necrotizing sialometaplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 919: Line 982:
 
|
 
|
 
|-
 
|-
−
|[[GTS5:BAP1-related_tumour_predisposition_syndrome_(BAP1)|BAP1-related tumour predisposition syndrome (BAP1)]]
+
|[[HAN5:Multifocal_epithelial_hyperplasia|Multifocal epithelial hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oral_melanoacanthoma|Oral melanoacanthoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_papilloma|Squamous papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oral_potentially_malignant_disorders|Oral potentially malignant disorders]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oral_epithelial_dysplasia|Oral epithelial dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Proliferative_verrucous_leukoplakia|Proliferative verrucous leukoplakia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Submucous_fibrosis|Submucous fibrosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:HPV-associated_oral_epithelial_dysplasia|HPV-associated oral epithelial dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Oral_squamous_cell_carcinoma|Oral squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Verrucous_carcinoma_of_the_oral_cavity_and_mobile_tongue|Verrucous carcinoma of the oral cavity and mobile tongue]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Carcinoma_cuniculatum|Carcinoma cuniculatum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Congenital_granular_cell_epulis|Congenital granular cell epulis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ectomesenchymal_chondromyxoid_tumour|Ectomesenchymal chondromyxoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Melanotic_neuroectodermal_tumour_of_infancy|Melanotic neuroectodermal tumour of infancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 7 (OROPHARYNGEAL TUMOURS (BASE OF TONGUE, TONSILS, ADNOIDS)) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Hamartomatous_polyps|Hamartomatous polyps]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_cell_carcinoma,_HPV-associated|Squamous cell carcinoma, HPV-associated]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_cell_carcinoma,_HPV-independent|Squamous cell carcinoma, HPV-independent]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 8 (ODONTOGENIC AND MAXILLOFACIAL BONE TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Radicular_cyst|Radicular cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Inflammatory_collateral_cysts|Inflammatory collateral cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Surgical_ciliated_cyst|Surgical ciliated cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Nasopalatine_duct_cyst|Nasopalatine duct cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Gingival_cysts|Gingival cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Dentigerous_cyst|Dentigerous cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Orthokeratinized_odontogenic_cyst|Orthokeratinized odontogenic cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lateral_periodontal_cyst_and_botryoid_odontogenic_cyst|Lateral periodontal cyst and botryoid odontogenic cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Calcifying_odontogenic_cyst|Calcifying odontogenic cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Glandular_odontogenic_cyst|Glandular odontogenic cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_keratocyst|Odontogenic keratocyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Adenomatoid_odontogenic_tumour|Adenomatoid odontogenic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_odontogenic_tumour|Squamous odontogenic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Calcifying_epithelial_odontogenic_tumour|Calcifying epithelial odontogenic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastoma,_unicystic|Ameloblastoma, unicystic]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastoma,_extraosseous/peripheral|Ameloblastoma, extraosseous/peripheral]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastoma,_conventional|Ameloblastoma, conventional]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Adenoid_ameloblastoma|Adenoid ameloblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Metastasizing_ameloblastoma|Metastasizing ameloblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontoma|Odontoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Primordial_odontogenic_tumour|Primordial odontogenic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastic_fibroma|Ameloblastic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Dentinogenic_ghost_cell_tumour|Dentinogenic ghost cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_fibroma|Odontogenic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cementoblastoma|Cementoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cemento-ossifying_fibroma|Cemento-ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_myxoma|Odontogenic myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Sclerosing_odontogenic_carcinoma|Sclerosing odontogenic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ameloblastic_carcinoma|Ameloblastic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Clear_cell_odontogenic_carcinoma|Clear cell odontogenic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ghost_cell_odontogenic_carcinoma|Ghost cell odontogenic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Primary_intraosseous_carcinoma_NOS|Primary intraosseous carcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_carcinosarcoma|Odontogenic carcinosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Odontogenic_sarcomas|Odontogenic sarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Central_giant_cell_granuloma|Central giant cell granuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Peripheral_giant_cell_granuloma|Peripheral giant cell granuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cherubism|Cherubism]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Simple_bone_cyst|Simple bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cemento-osseous_dysplasia|Cemento-osseous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Segmental_odontomaxillary_dysplasia|Segmental odontomaxillary dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Fibrous_dysplasia|Fibrous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Juvenile_trabecular_ossifying_fibroma|Juvenile trabecular ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Psammomatoid_ossifying_fibroma|Psammomatoid ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Familial_gigantiform_cementoma|Familial gigantiform cementoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Osteoma|Osteoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Osteochondroma|Osteochondroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Osteoblastoma|Osteoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Chondroblastoma|Chondroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Osteosarcoma_of_the_jaw|Osteosarcoma of the jaw]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:The_chondrosarcoma_family_of_tumours|The chondrosarcoma family of tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Rhabdomyosarcoma_with_TFCP2_rearrangement_|Rhabdomyosarcoma with TFCP2 rearrangement]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 9 (EAR TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Chondrodermatitis_nodularis_chronica_helicis|Chondrodermatitis nodularis chronica helicis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cystic_chondromalacia|Cystic chondromalacia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Exostosis_(osteoma)_of_the_ear|Exostosis (osteoma) of the ear]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ceruminous_adenoma|Ceruminous adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ceruminous_adenocarcinoma|Ceruminous adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_cell_carcinoma_of_the_external_auditory_canal|Squamous cell carcinoma of the external auditory canal]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Otosclerosis|Otosclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cholesteatoma|Cholesteatoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Middle_ear_papilloma|Middle ear papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Vestibular_schwannoma|Vestibular schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Middle_ear_neuroendocrine_tumour|Middle ear neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Endolymphatic_sac_tumour|Endolymphatic sac tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Middle_ear_squamous_cell_carcinoma|Middle ear squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Middle_ear_adenocarcinoma|Middle ear adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 10 (SOFT TISSUE TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Lipomas|Lipomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Liposarcomas|Liposarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Nodular_fasciitis|Nodular fasciitis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Haemangioma|Haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lymphangioma|Lymphangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Kaposi_sarcoma|Kaposi sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Myofibroma|Myofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Leiomyoma|Leiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Smooth_muscle_tumour_of_uncertain_malignant_potential|Smooth muscle tumour of uncertain malignant potential]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Rhabdomyoma|Rhabdomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Rhabdomyosarcomas|Rhabdomyosarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Chondroma|Chondroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Neuromas_|Neuromas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Myxoma_|Myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Extraskeletal_myxoid_chondrosarcoma|Extraskeletal myxoid chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:GLI1-altered_soft_tissue_tumour_|GLI1-altered soft tissue tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 11 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Reactive_lymphoid_hyperplasia|Reactive lymphoid hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:EBV-positive_mucocutaneous_ulcer|EBV-positive mucocutaneous ulcer]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:IgG4-related_disease|IgG4-related disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Extramedullary_myeloid_sarcoma|Extramedullary myeloid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Mantle_cell_lymphoma|Mantle cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Follicular_lymphoma|Follicular lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Paediatric-type_follicular_lymphoma|Paediatric-type follicular lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Large_B-cell_lymphoma_with_IRF4_rearrangement|Large B-cell lymphoma with IRF4 rearrangement]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Burkitt_lymphoma|Burkitt lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Plasmacytoma|Plasmacytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:T-lymphoblastic_leukaemia/lymphoma|T-lymphoblastic leukaemia/lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Primary_mucosal_CD30-positive_T-cell_lymphoproliferative_disorder|Primary mucosal CD30-positive T-cell lymphoproliferative disorder]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Extranodal_NK/T-cell_lymphoma|Extranodal NK/T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Hodgkin_lymphoma|Hodgkin lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 12 (MELANOCYTIC TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Mucosal_melanoma|Mucosal melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 13 (TUMOURS AND TUMOUR-IIKE LESIONS OF THE NECK AND LYMPH NODES) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Ranula|Ranula]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Lymphoepithelial_cyst|Lymphoepithelial cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Branchial_cleft_cyst|Branchial cleft cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Dermoid_and_teratoid_cysts|Dermoid and teratoid cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Branchioma|Branchioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Heterotopia-associated_carcinoma|Heterotopia-associated carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Squamous_carcinoma_of_unknown_primary_site|Squamous carcinoma of unknown primary site]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 14 (GERM CELL TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Germ_cell_tumours_of_the_head_and_neck|Germ cell tumours of the head and neck]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 15 (METASTASIS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Metastases_to_the_head_and_neck_region|Metastases to the head and neck region]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 16 (NEUROENDOCRINE NEOPLASMS AND PARAGANGLIOMA) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Neuroendocrine_tumour|Neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ectopic_or_invasive_PitNET_/_pituitary_adenoma|Ectopic or invasive PitNET / pituitary adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Head_and_neck_paraganglioma|Head and neck paraganglioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 17 (GENETIC TUMOUR SYNDROMES INVOLVING THE HEAD AND NECK) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[HAN5:Naevoid_basal_cell_carcinoma_syndrome_(Gorlin_syndrome)|Naevoid basal cell carcinoma syndrome (Gorlin syndrome)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[HAN5:Familial_adenomatous_polyposis_and_Gardner_syndrome|Familial adenomatous polyposis and Gardner syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[HAN5:Brooke-Spiegler_syndrome|Brooke-Spiegler syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Cowden_syndrome|Cowden syndrome]]
 +
|Disease
 +
|[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[HAN5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[HAN5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[HAN5:Fanconi_anaemia|Fanconi anaemia]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[HAN5:Dyskeratosis_congenita|Dyskeratosis congenita]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[HAN5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[HAN5:Bloom_syndrome|Bloom syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[HAN5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[HAN5:Tuberous_sclerosis|Tuberous sclerosis]]
 
|Disease
 
|Disease
 
|
 
|

Latest revision as of 14:07, 10 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Head and Neck Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (NASAL, PARANASAL, AND SKULL BASE TUMOURS)
Respiratory epithelial adenomatoid hamartoma Disease
Seromucinous hamartoma Disease
Nasal chondromesenchymal hamartoma Disease
Sinonasal papilloma, inverted type Disease
Sinonasal papilloma, oncocytic type Disease
Sinonasal papilloma, exophytic type Disease
Keratinizing squamous cell carcinoma Disease
Non-keratinizing squamous cell carcinoma Disease
NUT carcinoma Disease
SWI/SNF complex-deficient sinonasal carcinoma Disease
Sinonasal lymphoepithelial carcinoma Disease
Sinonasal undifferentiated carcinoma Disease
Teratocarcinosarcoma Disease
HPV-associated multiphenotypic sinonasal carcinoma Disease
Intestinal-type sinonasal adenocarcinoma Disease
Non-intestinal-type sinonasal adenocarcinoma Disease
Sinonasal tract angiofibroma Disease
Sinonasal glomangiopericytoma Disease
Biphenotypic sinonasal sarcoma Disease
Chordoma Disease
Sinonasal ameloblastoma Disease
Adamantinomatous craniopharyngioma Disease
Meningioma of the sinonasal tract, ear, and temporal bone Disease
Olfactory neuroblastoma Disease

CHAPTER 3 (NASOPHARYNGEAL TUMOURS)
Hairy polyp Disease
Salivary gland anlage tumour Disease
Low-grade nasopharyngeal papillary adenocarcinoma Disease
Nasopharyngeal carcinoma Disease

CHAPTER 4 (HYPOPHARYNGEAL, LARYNGEAL, TRACHEA, AND PARAPHARYNGEAL TUMOURS)
Squamous papilloma and papillomatosis Disease
Laryngeal and hypopharyngeal epithelial dysplasia Disease
Conventional squamous cell carcinoma Disease
Verrucous carcinoma of the hypopharynx, larynx, trachea, and parapharyngeal space Disease
Basaloid squamous cell carcinoma Disease
Papillary squamous cell carcinoma Disease
Spindle cell squamous carcinoma Disease
Adenosquamous carcinoma Disease
Lymphoepithelial carcinoma of the larynx Disease
Laryngeal cartilaginous tumours Disease

CHAPTER 5 (SALIVARY GLAND TUMOURS)
Nodular oncocytic hyperplasia Disease
Lymphoepithelial sialadenitis Disease
Pleomorphic adenoma Disease
Basal cell adenoma Disease
Warthin tumour Disease
Oncocytoma Disease
Salivary gland myoepithelioma Disease
Canalicular adenoma Disease
Cystadenoma of the salivary glands Disease
Ductal papillomas Disease
Sialadenoma papilliferum Disease
Lymphadenoma Disease
Sebaceous adenoma Disease
Intercalated duct adenoma and hyperplasia Disease
Striated duct adenoma Disease
Sclerosing polycystic adenoma Disease
Keratocystoma Disease
Mucoepidermoid carcinoma Disease
Adenoid cystic carcinoma Disease
Acinic cell carcinoma Disease
Secretory carcinoma Disease
Microsecretory adenocarcinoma Disease
Polymorphous adenocarcinoma Disease
Hyalinizing clear cell carcinoma Disease
Basal cell adenocarcinoma Disease
Intraductal carcinoma Disease
Salivary duct carcinoma Disease
Myoepithelial carcinoma Disease
Epithelial-myoepithelial carcinoma Disease
Mucinous adenocarcinoma Disease
Sclerosing microcystic adenocarcinoma Disease
Carcinoma ex pleomorphic adenoma Disease
Carcinosarcoma of the salivary glands Disease
Sebaceous adenocarcinoma Disease
Lymphoepithelial carcinoma Disease
Squamous cell carcinoma Disease
Sialoblastoma Disease
Salivary carcinoma NOS and emerging entities Disease
Sialolipoma Disease

CHAPTER 6 (ORAL CAVITY AND MOBILE TONGUE TUMOURS)
Necrotizing sialometaplasia Disease
Multifocal epithelial hyperplasia Disease
Oral melanoacanthoma Disease
Squamous papilloma Disease
Oral potentially malignant disorders Disease
Oral epithelial dysplasia Disease
Proliferative verrucous leukoplakia Disease
Submucous fibrosis Disease
HPV-associated oral epithelial dysplasia Disease
Oral squamous cell carcinoma Disease
Verrucous carcinoma of the oral cavity and mobile tongue Disease
Carcinoma cuniculatum Disease
Congenital granular cell epulis Disease
Granular cell tumour Disease
Ectomesenchymal chondromyxoid tumour Disease
Melanotic neuroectodermal tumour of infancy Disease

CHAPTER 7 (OROPHARYNGEAL TUMOURS (BASE OF TONGUE, TONSILS, ADNOIDS))
Hamartomatous polyps Disease
Squamous cell carcinoma, HPV-associated Disease
Squamous cell carcinoma, HPV-independent Disease

CHAPTER 8 (ODONTOGENIC AND MAXILLOFACIAL BONE TUMOURS)
Radicular cyst Disease
Inflammatory collateral cysts Disease
Surgical ciliated cyst Disease
Nasopalatine duct cyst Disease
Gingival cysts Disease
Dentigerous cyst Disease
Orthokeratinized odontogenic cyst Disease
Lateral periodontal cyst and botryoid odontogenic cyst Disease
Calcifying odontogenic cyst Disease
Glandular odontogenic cyst Disease
Odontogenic keratocyst Disease
Adenomatoid odontogenic tumour Disease
Squamous odontogenic tumour Disease
Calcifying epithelial odontogenic tumour Disease
Ameloblastoma, unicystic Disease
Ameloblastoma, extraosseous/peripheral Disease
Ameloblastoma, conventional Disease
Adenoid ameloblastoma Disease
Metastasizing ameloblastoma Disease
Odontoma Disease
Primordial odontogenic tumour Disease
Ameloblastic fibroma Disease
Dentinogenic ghost cell tumour Disease
Odontogenic fibroma Disease
Cementoblastoma Disease
Cemento-ossifying fibroma Disease
Odontogenic myxoma Disease
Sclerosing odontogenic carcinoma Disease
Ameloblastic carcinoma Disease
Clear cell odontogenic carcinoma Disease
Ghost cell odontogenic carcinoma Disease
Primary intraosseous carcinoma NOS Disease
Odontogenic carcinosarcoma Disease
Odontogenic sarcomas Disease
Central giant cell granuloma Disease
Peripheral giant cell granuloma Disease
Cherubism Disease
Aneurysmal bone cyst Disease
Simple bone cyst Disease
Cemento-osseous dysplasia Disease
Segmental odontomaxillary dysplasia Disease
Fibrous dysplasia Disease
Juvenile trabecular ossifying fibroma Disease
Psammomatoid ossifying fibroma Disease
Familial gigantiform cementoma Disease
Osteoma Disease
Osteochondroma Disease
Osteoblastoma Disease
Chondroblastoma Disease
Chondromyxoid fibroma Disease
Desmoplastic fibroma of bone Disease
Osteosarcoma of the jaw Disease
The chondrosarcoma family of tumours Disease
Mesenchymal chondrosarcoma Disease
Rhabdomyosarcoma with TFCP2 rearrangement Disease

CHAPTER 9 (EAR TUMOURS)
Chondrodermatitis nodularis chronica helicis Disease
Cystic chondromalacia Disease
Exostosis (osteoma) of the ear Disease
Ceruminous adenoma Disease
Ceruminous adenocarcinoma Disease
Squamous cell carcinoma of the external auditory canal Disease
Otosclerosis Disease
Cholesteatoma Disease
Middle ear papilloma Disease
Vestibular schwannoma Disease
Middle ear neuroendocrine tumour Disease
Endolymphatic sac tumour Disease
Middle ear squamous cell carcinoma Disease
Middle ear adenocarcinoma Disease

CHAPTER 10 (SOFT TISSUE TUMOURS)
Lipomas Disease
Liposarcomas Disease
Nodular fasciitis Disease
Desmoid fibromatosis Disease
Solitary fibrous tumour Disease
Low-grade myofibroblastic sarcoma Disease
Inflammatory myofibroblastic tumour Disease
Haemangioma Disease
Epithelioid haemangioma Disease
Lymphangioma Disease
Epithelioid haemangioendothelioma Disease
Kaposi sarcoma Disease
Angiosarcoma Disease
Myofibroma Disease
Leiomyoma Disease
EBV-associated smooth muscle tumour Disease
Smooth muscle tumour of uncertain malignant potential Disease
Leiomyosarcoma Disease
Rhabdomyoma Disease
Rhabdomyosarcomas Disease
Chondroma Disease
Neurofibroma Disease
Schwannoma Disease
Neuromas Disease
Malignant peripheral nerve sheath tumour Disease
Phosphaturic mesenchymal tumour Disease
Myxoma Disease
Extraskeletal myxoid chondrosarcoma Disease
Synovial sarcoma Disease
GLI1-altered soft tissue tumour Disease
Undifferentiated sarcoma Disease
Ewing sarcoma Disease

CHAPTER 11 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA)
Reactive lymphoid hyperplasia Disease
EBV-positive mucocutaneous ulcer Disease
IgG4-related disease Disease
Extramedullary myeloid sarcoma Disease
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) Disease
Mantle cell lymphoma Disease
Follicular lymphoma Disease
Paediatric-type follicular lymphoma Disease
Large B-cell lymphoma with IRF4 rearrangement Disease
Diffuse large B-cell lymphoma Disease
Burkitt lymphoma Disease
Plasmacytoma Disease
Plasmablastic lymphoma Disease
T-lymphoblastic leukaemia/lymphoma Disease
Primary mucosal CD30-positive T-cell lymphoproliferative disorder Disease
Extranodal NK/T-cell lymphoma Disease
Hodgkin lymphoma Disease
Juvenile xanthogranuloma Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Langerhans cell histiocytosis Disease
Follicular dendritic cell sarcoma Disease

CHAPTER 12 (MELANOCYTIC TUMOURS)
Mucosal melanoma Disease

CHAPTER 13 (TUMOURS AND TUMOUR-IIKE LESIONS OF THE NECK AND LYMPH NODES)
Ranula Disease
Lymphoepithelial cyst Disease
Branchial cleft cyst Disease
Thyroglossal duct cyst Disease
Dermoid and teratoid cysts Disease
Branchioma Disease
Heterotopia-associated carcinoma Disease
Squamous carcinoma of unknown primary site Disease

CHAPTER 14 (GERM CELL TUMOURS)
Germ cell tumours of the head and neck Disease

CHAPTER 15 (METASTASIS)
Metastases to the head and neck region Disease

CHAPTER 16 (NEUROENDOCRINE NEOPLASMS AND PARAGANGLIOMA)
Neuroendocrine tumour Disease
Ectopic or invasive PitNET / pituitary adenoma Disease
Small cell neuroendocrine carcinoma Disease
Large cell neuroendocrine carcinoma Disease
Merkel cell carcinoma Disease
Head and neck paraganglioma Disease

CHAPTER 17 (GENETIC TUMOUR SYNDROMES INVOLVING THE HEAD AND NECK)
Naevoid basal cell carcinoma syndrome (Gorlin syndrome) Disease
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial adenomatous polyposis and Gardner syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Brooke-Spiegler syndrome Disease
Cowden syndrome Disease See DIG5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial paraganglioma syndromes Disease
Multiple endocrine neoplasia type 2 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Hyperparathyroidism-jaw tumour syndrome Disease
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Fanconi anaemia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Dyskeratosis congenita Disease
Ataxia-telangiectasia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Bloom syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Tuberous sclerosis Disease


Retrieved from "https://ccga.io/index.php?title=HAN5:Volunteer_Assignments_and_Opportunities&oldid=15422"